Interaction of academic medical research centers with the pharmaceutic
al and biotechnology industries is essential for progress in exploring
new avenues for therapy of breast cancer. This special issue of Breas
t Cancer Research and Treatment reports the proceedings of a conferenc
e held by the Lombardi Cancer Center, Georgetown University, on progre
ss toward development of new therapies for breast cancer. These chapte
rs are organized to present the following topics: immunotherapy, tumor
growth pathways and their inhibition, and tumor-host interaction path
ways and their inhibition.